Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions.
Elagolix is a short-acting oral gonadotropin-releasing hormone antagonist utilized for treating endometriosis-associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical data regarding its use …
Endometriosis, Anxiety, Allergic Rhinoconjunctivitis and Asthma: A population-based study.
To evaluate the association between endometriosis, anxiety, allergic rhinoconjunctivitis and asthma in hospitalized women, and to determine the role of age.